Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SET pseudogene 22 (SETP22)
- Target
- SETP22
- Molecular classification
- Other (Pseudogene)
01
Overview
SET pseudogene 22 (SETP22) is a non-functional genomic locus similar in sequence to the active SET nuclear proto-oncogene, but lacking the ability to produce a functional protein[1][2]. Pseudogenes such as SETP22 arise by mutation or genome rearrangement of an ancestral gene and typically accumulate changes that disable protein-coding capacity[6][12]. While some pseudogenes are transcribed and may regulate their parent genes or function as non-coding RNAs, there is currently no evidence that SETP22 possesses biological activity or disease association[1][2][5]. Consequently, SETP22 is not considered a therapeutic target or biomarker. If you need information about the functional protein "SET nuclear proto-oncogene" (abbreviated as SET), which has established cellular roles and is discussed as a therapeutic target, let me know.
- Other names
- SETP22
02
Mechanism of action
None
03
Biological functions
None established for this pseudogeneSome pseudogenes can participate in gene regulation by acting as competing endogenous RNAs or influencing microRNA activity, but there is no specific evidence for SETP22
04
Disease associations
None establishedPseudogenes, including those related to SET, have been implicated in some regulatory contexts, cancer, and gene network modulation; however, this is not specifically established for SETP22
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on SET pseudogene 22 (SETP22).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SET pseudogene 22 (SETP22).